Log in to search using one of your social media accounts:

 

Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma
Condition:   Tongue Squamous Cell Carcinoma Interventions:   Procedure: contralateral submental flap for tongue cancer defect;   Procedure: primary closure for tongue cancer defect Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Individualized Pharmaceutical-care in Outpatients With Cancer Pain
Condition:   Cancer Pain Intervention:   Other: Pharmaceutical care Sponsor:   Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Sorafenib and Nivolumab as First-Line Therapy in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer
Conditions:   Stage III Hepatocellular Carcinoma AJCC v8;   Stage IIIA Hepatocellular Carcinoma AJCC v8;   Stage IIIB Hepatocellular Carcinoma AJCC v7;   Stage IIIC Hepatocellular Carcinoma AJCC v7;   Stage IV Hepatocellular Carcinoma AJCC v8;   Stage IVA Hepatocellular Carcin oma AJCC v8;   Stage IVB Hepatocellular Carcinoma AJCC v8 Interventions:   Other: Laboratory Biomarker Analysis;   Bi...
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
Condition:   Advanced Solid Tumors Intervention:   Drug: PT-112 Injection Sponsor:   SciClone Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Determinants of Resistance to First-line Therapy With an AI and Palbociclib for HR+ MBC
Condition:   Breast Cancer Intervention:   Drug: Aromatase Inhibitor and Palbociclib Sponsor:   Sidney Kimmel Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Needlescopic-assisted Uniportal vs Uniportal VATS
Conditions:   Lung Cancer;   Lung Cancer Metastatic;   Bullous Disease Lung;   Nodule Solitary Pulmonary;   Mediastinal Tumor Intervention:   Procedure: Thoracoscopic surgery Sponsor:   National Taiwan University Hospital Hsin-Chu Branch Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

ABI-009 (Nab-rapamycin) in Combination With FOLFOX and Bevacizumab as First-line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Condition:   Colorectal Cancer Metastatic Intervention:   Drug: ABI-009; nab-rapamycin; albumin-bound rapamycin Sponsor:   Aadi, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer
Condition:   Carcinoma, Non-Small-Cell Lung Intervention:   Drug: PF-06463922 (Lorlatinb) Sponsors:   Fondazione Ricerca Traslazionale;   Clinical Research Technology S.r.l. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole
Condition:   Breast Cancer Interventions:   Drug: Ribociclib;   Drug: Letrozole Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
Condition:   Prostate Cancer Interventions:   Drug: PET/MRI with Gallium-68 labeled PSMA-HBED-CC;   Drug: Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC;   Drug: PET/CT with Gallium-68 labeled PSMA-HBED-CC Sponsor:   Weill Medical College of Cornell University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Prior Axitinib as a Determinant of Outcome of Renal Surgery
Condition:   Clear Cell Renal Cell Carcinoma Intervention:   Drug: Axitinib Oral Tablet [Inlyta] Sponsors:   Ithaar Derweesh;   The Cleveland Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers
Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Male Genital Organs;   Human Papilloma Virus Interventions:   Biological: MEDI0457;   Drug: Durvalumab;   Procedure: Electroporation Sponsors:   M.D. Anderson Cancer Center;   AstraZeneca;   Inovio Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent
Condition:   Malignant Biliary Stricture Interventions:   Procedure: Plastic stent anchoring;   Procedure: FCSEMS Sponsors:   Seoul National University Hospital;   Daewoong Pharmaceutical Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Oncological Outcome of Contralateral Submental Artery Island Flap Versus Primary Closure in Tongue Squamous Cell Carcinoma
Condition:   Tongue Squamous Cell Carcinoma Interventions:   Procedure: contralateral submental flap for tongue cancer defect;   Procedure: primary closure for tongue cancer defect Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Individualized Pharmaceutical-care in Outpatients With Cancer Pain
Condition:   Cancer Pain Intervention:   Other: Pharmaceutical care Sponsor:   Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Sorafenib and Nivolumab as First-Line Therapy in Treating Participants With Unresectable, Locally Advanced or Metastatic Liver Cancer
Conditions:   Stage III Hepatocellular Carcinoma AJCC v8;   Stage IIIA Hepatocellular Carcinoma AJCC v8;   Stage IIIB Hepatocellular Carcinoma AJCC v7;   Stage IIIC Hepatocellular Carcinoma AJCC v7;   Stage IV Hepatocellular Carcinoma AJCC v8;   Stage IVA Hepatocellular Carcin oma AJCC v8;   Stage IVB Hepatocellular Carcinoma AJCC v8 Interventions:   Other: Laboratory Biomarker Analysis;   Bi...
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
Condition:   Advanced Solid Tumors Intervention:   Drug: PT-112 Injection Sponsor:   SciClone Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Determinants of Resistance to First-line Therapy With an AI and Palbociclib for HR+ MBC
Condition:   Breast Cancer Intervention:   Drug: Aromatase Inhibitor and Palbociclib Sponsor:   Sidney Kimmel Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Needlescopic-assisted Uniportal vs Uniportal VATS
Conditions:   Lung Cancer;   Lung Cancer Metastatic;   Bullous Disease Lung;   Nodule Solitary Pulmonary;   Mediastinal Tumor Intervention:   Procedure: Thoracoscopic surgery Sponsor:   National Taiwan University Hospital Hsin-Chu Branch Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

ABI-009 (Nab-rapamycin) in Combination With FOLFOX and Bevacizumab as First-line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Condition:   Colorectal Cancer Metastatic Intervention:   Drug: ABI-009; nab-rapamycin; albumin-bound rapamycin Sponsor:   Aadi, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer
Condition:   Carcinoma, Non-Small-Cell Lung Intervention:   Drug: PF-06463922 (Lorlatinb) Sponsors:   Fondazione Ricerca Traslazionale;   Clinical Research Technology S.r.l. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers
Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Male Genital Organs;   Human Papilloma Virus Interventions:   Biological: MEDI0457;   Drug: Durvalumab;   Procedure: Electroporation Sponsors:   M.D. Anderson Cancer Center;   AstraZeneca;   Inovio Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Study of the Molecular Features of Postmenopausal Women With HR+ HER2-negative aBC on First-line Treatment With Ribociclib and Letrozole
Condition:   Breast Cancer Interventions:   Drug: Ribociclib;   Drug: Letrozole Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer
Condition:   Prostate Cancer Interventions:   Drug: PET/MRI with Gallium-68 labeled PSMA-HBED-CC;   Drug: Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC;   Drug: PET/CT with Gallium-68 labeled PSMA-HBED-CC Sponsor:   Weill Medical College of Cornell University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent
Condition:   Malignant Biliary Stricture Interventions:   Procedure: Plastic stent anchoring;   Procedure: FCSEMS Sponsors:   Seoul National University Hospital;   Daewoong Pharmaceutical Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Prior Axitinib as a Determinant of Outcome of Renal Surgery
Condition:   Clear Cell Renal Cell Carcinoma Intervention:   Drug: Axitinib Oral Tablet [Inlyta] Sponsors:   Ithaar Derweesh;   The Cleveland Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2018 Category: Research Source Type: clinical trials

Endometrial Cancer Lymphadenectomy Trial
Conditions:   Cancer of Endometrium Stage I;   Cancer of Endometrium Stage II Interventions:   Procedure: Standard surgical procedure for endometrial cancer;   Procedure: systematic lymphadenectomy (LNE) Sponsors:   Philipps University Marburg Medical Center;   German Cancer Aid Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

A Trial of Tisotumab Vedotin in Cervical Cancer
Condition:   Cervical Cancer Intervention:   Drug: tisotumab vedotin Sponsors:   Genmab;   Seattle Genetics, Inc.;   European Network of Gynaecological Oncological Trial Groups (ENGOT);   Belgian Gynaecological Oncology Group;   Gynecologic Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Multi-peptide CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Conditions:   Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia in Remission;   Bone Marrow Transplantation Recipient;   Chronic Lymphocytic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematopoietic Cell Transplantation Recipient;   Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Myeloproliferative Neoplasm;   Non-Hodgkin Lymphoma ...
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Study Evaluating CMP-001 in Combination With Atezolizumab in Subjects With Non-Small Cell Lung Cancer
Condition:   Non Small Cell Lung Cancer Interventions:   Drug: CMP-001;   Drug: Atezolizumab;   Radiation: Radiation Therapy Sponsors:   Checkmate Pharmaceuticals;   Novella Clinical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Protein Intake Associated With Physical Activity Related to Specific Outcomes
Conditions:   Cancer;   Critically Ill;   Surgery Interventions:   Dietary Supplement: Intervention;   Dietary Supplement: Control Sponsor:   University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC
Condition:   Metastatic Castration-Resistant Prostate Cancer Interventions:   Drug: CORT125281;   Drug: Enzalutamide (Xtandi) Sponsor:   Corcept Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

BrUOG 351: PRE-OPERATIVE APBI USING NIBB
Conditions:   Breast Cancer;   Invasive Breast Cancer;   Ductal Carcinoma in Situ Interventions:   Radiation: NIBB: accuboost;   Procedure: Partial mastectomy Sponsors:   Jaroslaw Hepel;   Brown University Oncology Research Group;   Rhode Island Hospital;   Women and Infants Hospital of Rhode Island Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China
Conditions:   Breast Cancer;   Neoadjuvant Therapy;   Neoplasm Staging;   Estrogen Receptor;   Histological Grade;   HER2;   Prognosis;   Predictive Value of Tests Intervention:   Sponsor:   Peking University First Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Psyhosomatic Medicine in Oncologic and Cardiac Disease Study
Conditions:   Acute Myocardial Infarction;   Tako Tsubo Cardiomyopathy;   Breast Cancer Intervention:   Behavioral: Short Term Psychotherapy Sponsor:   San Filippo Neri General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Combination of Chemoradiation With Immunotherapy in Inoperable Å“sophageal Cancer
Condition:   Inoperable œsophageal Cancer Interventions:   Drug: Nivolumab;   Drug: Ipilimumab;   Other: Chemoradiation Sponsor:   European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation
Condition:   Breast Cancer Intervention:   Radiation: Radiation Therapy (RT) Sponsor:   New York University School of Medicine Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants
Condition:   Locally Advanced or Metastatic Breast Cancer Intervention:   Drug: Eribulin mesylate Sponsor:   Eisai Korea Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III
Condition:   Testicular Neoplasm Intervention:   Diagnostic Test: MRI with DWI vs CT Sponsor:   Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Condition:   Mesothelioma Interventions:   Drug: LMB-100;   Drug: SEL-110 Sponsor:   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Accelerated Partial Breast Irradiation Study
Condition:   Breast Cancer Female Interventions:   Device: Balloon Brachytherapy;   Radiation: 3D Conformal External Beam Irradiation Sponsor:   Sentara Norfolk General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
Condition:   Local Recurrence of Malignant Tumor of Prostate Intervention:   Radiation: Stereotactic Body Radiotherapy Sponsor:   UNICANCER Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Condition:   Prostatic Neoplasms Intervention:   Drug: Zolpidem Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III
Condition:   Testicular Neoplasm Intervention:   Diagnostic Test: MRI with DWI vs CT Sponsor:   Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Condition:   Mesothelioma Interventions:   Drug: LMB-100;   Drug: SEL-110 Sponsor:   National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
Condition:   Local Recurrence of Malignant Tumor of Prostate Intervention:   Radiation: Stereotactic Body Radiotherapy Sponsor:   UNICANCER Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Endometrial Cancer Lymphadenectomy Trial
Conditions:   Cancer of Endometrium Stage I;   Cancer of Endometrium Stage II Interventions:   Procedure: Standard surgical procedure for endometrial cancer;   Procedure: systematic lymphadenectomy (LNE) Sponsors:   Philipps University Marburg Medical Center;   German Cancer Aid Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

A Trial of Tisotumab Vedotin in Cervical Cancer
Condition:   Cervical Cancer Intervention:   Drug: tisotumab vedotin Sponsors:   Genmab;   Seattle Genetics, Inc.;   European Network of Gynaecological Oncological Trial Groups (ENGOT);   Belgian Gynaecological Oncology Group;   Gynecologic Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Multi-peptide CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Conditions:   Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Acute Lymphoblastic Leukemia in Remission;   Acute Myeloid Leukemia in Remission;   Bone Marrow Transplantation Recipient;   Chronic Lymphocytic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematopoietic Cell Transplantation Recipient;   Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Myeloproliferative Neoplasm;   Non-Hodgkin Lymphoma ...
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials

Study Evaluating CMP-001 in Combination With Atezolizumab in Subjects With Non-Small Cell Lung Cancer
Condition:   Non Small Cell Lung Cancer Interventions:   Drug: CMP-001;   Drug: Atezolizumab;   Radiation: Radiation Therapy Sponsors:   Checkmate Pharmaceuticals;   Novella Clinical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2018 Category: Research Source Type: clinical trials